The healthcare sector is evolving. Medical monitoring apps, artificial intelligence capable of analyzing X-rays, and platforms that connect patients and healthcare professionals: these transformations go by one name—healthtech. They are driven by innovative companies, public and private investments, and the growing use of health data.

In France, this movement has become a strategic priority. It impacts research, the organization of care, the training of healthcare professionals, and the way patients access medical information. But what does healthtech actually encompass, how does its ecosystem function in our country, and what opportunities does it hold for the years ahead?

What Is Healthtech?

Healthtech refers to all companies, technologies, and solutions aimed at improving prevention, diagnosis, treatment, patient monitoring, or the organization of the healthcare system through digital technology and applied sciences. The term encompasses a wide range of applications, from a mobile app for pregnancy tracking to a diagnostic-assistance algorithm used in radiology.

This broad scope explains why healthtech encompasses several categories of innovation, from connected medical devices to technologies derived from deep tech.

Healthtech, medtech, digital health: concepts that should be distinguished

These three terms often overlap in everyday language, but they do not refer to exactly the same thing.

Healthtech is the broadest term. It encompasses all technological innovations applied to healthcare, whether digital, hardware-based, or biotechnological.

Medtech, short for “medical technology,” focuses on medical devices and medical technologies in the strict sense: implants, imaging equipment, surgical instruments, or connected devices subject to specific regulations, namely the Medical Device Regulation (MDR).

Finally, digital health refers more specifically to digital tools and data applied to the healthcare system: telemedicine, monitoring apps, medical data exchange platforms, and diagnostic artificial intelligence.

A startup developing a connected wristband that measures heart rate falls under both medtech—for the physical device—and digital health—for the app that analyzes the collected data. It is this overlap between the categories that characterizes the healthtech ecosystem as a whole.

The State of the Healthtech Market in France

The French sector has reached an unprecedented level of maturity. Nearly 2,800 companies are active in biotechnology, medical devices, and digital health.

In Europe, private funding will account for about two-thirds of healthtech financing in 2025. French companies still raised 2.3 billion euros in 2025, despite a more selective global funding environment.

Financial markets are also playing an increasingly important role, with more than 100 HealthTech companies listed in Europe, a large proportion of which are French.

Public support remains an essential pillar of the market. The digital health component of France 2030 alone accounts for more than 650 million euros, dedicated in particular to medical cybersecurity, sovereign cloud infrastructure, and support for clinical validation. The Research Tax Credit also continues to support a large portion of companies engaged in health-related research and development projects.

The Key Players in the French Healthtech Sector

The ecosystem relies on a diverse range of players, each playing a specific role in the chain stretching from research to commercialization. At the forefront, startups and innovative young companies drive most of the sector’s visible momentum, soon to be joined by established SMEs that take over to support their international growth.

Major pharmaceutical and industrial groups are not to be outdone: rather than developing everything in-house, they are increasingly relying on open innovation by forming partnerships with young companies, particularly in the areas of biotherapies and medical technologies.

Upstream in this chain, healthcare institutions and universities serve as testing grounds for experimentation and clinical validation—an essential step before any product can be brought to market. Public and academic research organizations, for their part, feed the ecosystem with scientific discoveries that can be transformed into practical applications.

That leaves the question of funding and support, without which these innovations would struggle to see the light of day. Investors—whether venture capital funds or public entities—finance the various stages of development, while incubators and accelerators guide project leaders in structuring their businesses. Clusters and competitiveness hubs bring all these stakeholders together in a single region to foster joint projects.

The innovations shaping healthtech

The sector is advancing at a steady pace, driven by several families of technologies that overlap and reinforce one another.

Artificial Intelligence in Healthcare

Generative artificial intelligence has now established itself as one of the sector’s most prominent hallmarks. Nearly two-thirds of French healthtech companies—64%—report that they already use it in their operations. Adoption is particularly high in digital health, where it reaches 73%, and in medtech, at 70%.

Its practical applications include diagnostic assistance, the discovery of new molecules, risk prediction, and the personalization of care pathways. It plays a particularly significant role in medical imaging, where algorithms already assist radiologists in detecting certain anomalies, helping to reduce diagnostic turnaround times without replacing the healthcare professional’s clinical judgment. However, these applications raise issues of reliability, clinical validation, and explainability: an algorithm used in a medical context must be able to justify its recommendations, and its performance must be validated before any large-scale deployment.

Health Data and Data Science

Health data serves as the raw material for numerous innovations. It enables improved research, more targeted prevention, the evaluation of treatment effectiveness, and a better understanding of patient pathways at the population level.

In France, the Health Data Platform, better known as the Health Data Hub, plays a central role in this effort. This public interest group aggregates data from the National Health Data System and makes it available to researchers and project leaders, subject to strict regulations that ensure the public interest and the protection of personal data. This governance structure illustrates the sector’s specific requirements: the use of health data must always balance heightened security and confidentiality requirements.

Connected Medical Devices

Connected health devices—whether wearable sensors, remote monitoring devices, or connected medical equipment—are playing an increasingly important role in monitoring patients outside the hospital. They enable earlier detection of a deterioration in health and provide daily support for patients with chronic conditions, complementing the care provided by healthcare professionals.

Schools, incubators, events: where projects take shape

Healthcare innovations aren’t born solely in laboratories. They also take shape in places that bring together researchers, entrepreneurs, and healthcare professionals. In terms of education, digital health is now a mandatory part of healthcare curricula, and artificial intelligence is playing an increasingly important role. As a result, future healthcare providers are better prepared to use and evaluate healthtech tools. In terms of support, incubators, accelerators, and specialized campuses help startups move from idea to product, often in partnership with a hospital or research organization. For example, Tiers-Lieux d'Expérimentation (TLE), funded by France 2030, allow solutions to be tested under real-world conditions with patients and healthcare providers. Finally, industry events (trade shows, themed days, demo days) offer the opportunity to meet investors, industry partners, and early adopters. It’s best to target those that align with your stage of development rather than attending as many events as possible.

The Role of Startups in the Rise of French Healthtech

Startups play a central role in the sector’s momentum. Their ability to experiment quickly, collaborate with healthcare professionals, and adapt to on-the-ground needs makes them particularly active drivers of innovation.

Their journey follows a demanding path that goes far beyond mere technological invention. For solutions subject to medical regulations—particularly medical devices—clinical evaluations and compliance procedures may be required before the product can be brought to market.

Regulatory requirements for medical devices, the length of clinical validation cycles, and the need for specialized expertise—particularly in regulation and data science—represent critical milestones for these young companies. This is why the support provided by incubators and public funding continues to play a decisive role.

Start-ups and Regional Ecosystems: The Example of Île-de-France

Healthtech is not developing at the same pace throughout France. Each region brings together its own stakeholders: the Regional Health Agency (ARS), the regional council, the Bpifrance delegation, competitiveness clusters, university hospitals, and incubators... The Île-de-France region offers a particularly concentrated example of this. For instance, the Medicen Paris Region competitiveness cluster brings together more than 500 players in medtech, biotech, and e-health. South of Paris, within the Paris-Saclay area, the Genopole biocluster brings together nearly 80 biotechnology companies, laboratories, and a hospital. In Paris, PariSanté Campus unites startups, researchers, and institutions focused on AI and digital health. To test solutions under real-world conditions, the SANTINEL Tiers-lieu experimentation hub opens the 38 AP-HP hospitals to innovations in medical imaging and digital pathology. On the funding front, the Île-de-France Regional Health Agency (ARS) is issuing calls for projects on digitally-driven organizational innovations, and the Region supports innovation in partnership with Bpifrance, notably through Innov’Up. For a startup, the best approach is to identify these key contacts early on: it’s helpful to reach out to the Île-de-France Regional Health Agency (ARS) as early as the prototype phase.

France’s Support for Health Tech

Government authorities have implemented several initiatives to support the sector’s growth. The France 2030 plan is one of its pillars, featuring a digital health component with a budget of over 650 million euros, focused on medical cybersecurity, sovereign cloud infrastructure, and support for the clinical validation of innovations.

The Research Tax Credit complements this framework by reducing the tax burden on companies engaged in research and development projects—a particularly valuable form of support in a sector where innovation cycles are long and costly.

This public support also takes the form of a regional network: incubators, accelerators, and specialized clusters bring together researchers, entrepreneurs, healthcare institutions, and investors around shared projects, rather than allowing each stakeholder to work in isolation.

Opportunities Offered by Healthtech

These changes primarily benefit those driving innovation in the economic sphere. For an entrepreneur, healthtech remains a sector where many needs remain unmet—from prevention to care coordination, including remote monitoring and medical decision support. From an investor’s perspective, growth potential remains strong, driven by the widespread adoption of artificial intelligence and the gradual development of a more mature market, even as funding cycles have lengthened.

In terms of innovation, opportunities often take the form of calls for proposals and public grants: national programs under France 2030, calls for proposals from regional health agencies, grants from regional councils, or competitions dedicated to digital health. These programs have different timelines and eligibility criteria depending on the project’s maturity. G_NIUS lists digital health grants, which you can filter by region and type of support.

The impact is also being felt in clinical and scientific settings. Healthcare professionals are seeing the arrival of new diagnostic tools and new monitoring methods, which are transforming their day-to-day practices. Researchers, for their part, find in health tech a platform to showcase their work, particularly in the areas of health data, artificial intelligence, and collaborations with innovative companies.

Finally, there is the issue of skills. The sector is giving rise to new professions at the intersection of medicine, engineering, computer science, and regulation, which opens up concrete career opportunities for students and young professionals. The most sought-after profiles involve data science, artificial intelligence, cybersecurity, product development, and knowledge of the regulatory requirements specific to medical devices.

There are several pathways to acquiring these skills. In initial training, digital health is now integrated into the curricula of healthcare professions. Universities and schools also offer specialized degrees at the intersection of healthcare, data, and engineering. For continuing education, the ANS-Formation platform provides access to more than 110 online modules on key topics in the sector: health data, cybersecurity, artificial intelligence, and more. It is aimed at healthcare professionals and students, as well as industry representatives and project leaders who want to understand the framework within which their solutions will need to operate.

The Challenges of Health Tech

The sector must navigate specific requirements stemming from the fact that it directly impacts patient health and the work of healthcare professionals. Chief among these requirements is the certification of medical devices: a lengthy and rigorous process designed to ensure product safety before they are brought to market. Added to this is a tighter funding environment, with fundraising becoming scarcer and taking longer to finalize, not to mention the challenges of cybersecurity and health data protection, which are particularly sensitive in this sector.

Interoperability among different health information systems remains a significant technical barrier. Adoption by healthcare professionals and acceptance by patients are also by no means guaranteed: an innovation, no matter how effective, must still win over its users. Added to this are issues of the digital divide, staff training, and technological sovereignty—all of which are particularly sensitive when dealing with data as strategic as health data.

The Future of Health Tech in France

Several trends appear poised to shape the sector in the coming years. Artificial intelligence is expected to continue gaining ground, no longer as a mere technological option, but as a tool integrated into the daily practices of companies and healthcare professionals. Personalized medicine, which tailors treatments to each patient’s profile by leveraging increasingly detailed health data, is also continuing to advance.

The development of connected devices and remote monitoring is expected to continue supporting patient care outside the hospital, against the backdrop of an aging population and growing pressure on the healthcare system. The convergence of biotech, medtech, digital, and deep tech is also expected to intensify, further blurring the lines between these historically distinct categories.

At the European level, France retains strong assets: a well-structured ecosystem, consistent public support, and world-class research. However, the sector remains subject to intense international competition, particularly regarding financing and technological sovereignty, which will likely continue to shape the strategic decisions of French companies in the coming years.